RB and Sponsor Responsibilities Following SR/NSR Determination</u> </p>

<p><b>If the IRB decides the study is Significant Risk:</b></p>

<p>1. IRB Responsibilities: </p>

<blockquote>
  <p>Notify sponsor and investigator of SR decision <br>
  After IDE obtained by sponsor, proceed to review study applying requisite criteria [21 CFR
  56.111] </p>
</blockquote>

<p>2. Sponsor Responsibilities: </p>

<blockquote>
  <p>Submit IDE to FDA or, if electing not to proceed with study, notify FDA (CDR